Design of Microbubbles for Gene/Drug Delivery

Area of Science:

• Biomedical Engineering
• Pharmacology
• Medical Imaging

Background:

• Ultrasound contrast agents (UCA) are transitioning from diagnostic to therapeutic roles.
• Ultrasound (US) offers precise spatial control for triggered drug delivery, minimizing off-target effects.
• UCA imaging aids in target localization and real-time monitoring of drug release.

Purpose of the Study:

• To explore the evolving therapeutic applications of ultrasound contrast agents.
• To highlight the advantages of ultrasound-triggered drug delivery systems.
• To discuss the formulation and regulatory considerations for clinical translation.

Main Methods:

• Review of current research on UCA formulation and preparation.
• Analysis of analytical methods for UCA characterization.
• Examination of preclinical data and clinical trial limitations.

Main Results:

• Promising preclinical results demonstrate the potential of UCA-mediated drug delivery.
• Key clinical indications include cardiovascular diseases, central nervous system disorders, and cancer therapy.
• Challenges remain in translating these findings to widespread clinical practice.

Conclusions:

• Ultrasound contrast agents and US technology present a promising platform for targeted drug and gene delivery.
• Further research into UCA formulation and rigorous regulatory pathways are crucial for clinical adoption.
• Successful translation requires addressing formulation, analytical, and regulatory hurdles.